TreeWAS – Variant ID: rs1528010

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
H35.8 Other specified retinal disorders	0.000	0.952	0.048
H35.6 Retinal haemorrhage	0.000	0.959	0.041
H35 Other retinal disorders	0.000	0.961	0.039
H35.2 Other proliferative retinopathy	0.000	0.965	0.035
H35.5 Hereditary retinal dystrophy	0.000	0.966	0.034
H35.1 Retinopathy of prematurity	0.000	0.972	0.028
H35.9 Retinal disorder, unspecified	0.000	0.975	0.025
N85.0 Endometrial glandular hyperplasia	0.024	0.976	0.000
H35.4 Peripheral retinal degeneration	0.000	0.977	0.023
H35.3 Degeneration of macula and posterior pole	0.000	0.979	0.021
H35.7 Separation of retinal layers	0.000	0.979	0.020
C79.8 Secondary malignant neoplasm of other specified sites	0.019	0.981	0.000
H35.0 Background retinopathy and retinal vascular changes	0.000	0.983	0.017
T39.0 Salicylates	0.016	0.984	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.015	0.985	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.014	0.986	0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.013	0.987	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.013	0.987	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.013	0.987	0.000
T46.1 Calcium-channel blockers	0.012	0.988	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.012	0.988	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.012	0.988	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.012	0.988	0.000
T43.2 Other and unspecified antidepressants	0.012	0.988	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.012	0.988	0.000
T47.2 Stimulant laxatives	0.012	0.988	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.011	0.989	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.011	0.989	0.000
R03.1 Nonspecific low blood-pressure reading	0.000	0.989	0.011
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.011	0.989	0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.011	0.989	0.000
T39.4 Antirheumatics, not elsewhere classified	0.011	0.989	0.000
T39.2 Pyrazolone derivatives	0.011	0.989	0.000
T45.0 Antiallergic and antiemetic drugs	0.011	0.989	0.000
T43.0 Tricyclic and tetracyclic antidepressants	0.011	0.989	0.000
T45.5 Anticoagulants	0.010	0.990	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.010	0.990	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.010	0.990	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.010	0.990	0.000
T48.5 Anti-common-cold drugs	0.010	0.990	0.000
T38.0 Glucocorticoids and synthetic analogues	0.010	0.990	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.010	0.990	0.000
T36 Poisoning by systemic antibiotics	0.010	0.990	0.000
T38.1 Thyroid hormones and substitutes	0.010	0.990	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.010	0.990	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.010	0.990	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.010	0.990	0.000
T47.7 Emetics	0.010	0.990	0.000
T47.6 Antidiarrhoeal drugs	0.010	0.990	0.000
T47.5 Digestants	0.010	0.990	0.000
T47.4 Other laxatives	0.010	0.990	0.000
T47.3 Saline and osmotic laxatives	0.010	0.990	0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.010	0.990	0.000
T47.0 Histamine H(2)-receptor antagonists	0.009	0.990	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.009	0.991	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.009	0.991	0.000
T46.7 Peripheral vasodilators	0.009	0.991	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.009	0.991	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.009	0.991	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.009	0.991	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.009	0.991	0.000
T43.9 Psychotropic drug, unspecified	0.009	0.991	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.009	0.991	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.009	0.991	0.000
T45.8 Other primarily systemic and haematological agents	0.009	0.991	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.009	0.991	0.000
T45.6 Fibrinolysis-affecting drugs	0.009	0.991	0.000
T45.4 Iron and its compounds	0.009	0.991	0.000
T45.3 Enzymes, not elsewhere classified	0.009	0.991	0.000
T45.2 Vitamins, not elsewhere classified	0.009	0.991	0.000
T38.9 Other and unspecified hormone antagonists	0.009	0.991	0.000
T38.7 Androgens and anabolic congeners	0.009	0.991	0.000
T38.5 Other oestrogens and progestogens	0.009	0.991	0.000
T38.4 Oral contraceptives	0.009	0.991	0.000
T38.2 Antithyroid drugs	0.009	0.991	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.009	0.991	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.009	0.991	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.009	0.991	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.009	0.991	0.000
T48.4 Expectorants	0.009	0.991	0.000
T48.3 Antitussives	0.009	0.991	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.009	0.991	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.009	0.991	0.000
T48.0 Oxytocic drugs	0.009	0.991	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.009	0.991	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.009	0.991	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.009	0.991	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.009	0.991	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.008	0.992	0.000
K62.6 Ulcer of anus and rectum	0.008	0.992	0.000
C77.9 Lymph node, unspecified	0.008	0.992	0.000
T36.3 Macrolides	0.008	0.992	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.008	0.992	0.000
T37.5 Antiviral drugs	0.008	0.992	0.000
T37.4 Anthelminthics	0.008	0.992	0.000
T37.3 Other antiprotozoal drugs	0.008	0.992	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.008	0.992	0.000
T37.1 Antimycobacterial drugs	0.008	0.992	0.000
T37.0 Sulphonamides	0.008	0.992	0.000
T43.6 Psychostimulants with abuse potential	0.008	0.992	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.008	0.992	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.008	0.992	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.008	0.992	0.000
T41.5 Therapeutic gases	0.008	0.992	0.000
T41.4 Anaesthetic, unspecified	0.008	0.992	0.000
T41.3 Local anaesthetics	0.008	0.992	0.000
T41.2 Other and unspecified general anaesthetics	0.008	0.992	0.000
T41.1 Intravenous anaesthetics	0.008	0.992	0.000
T41.0 Inhaled anaesthetics	0.008	0.992	0.000
H30-H36 Disorders of choroid and retina	0.000	0.992	0.008
T42.0 Hydantoin derivatives	0.008	0.992	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.007	0.992	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.007	0.992	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.007	0.992	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.007	0.992	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.007	0.992	0.000
T44.0 Anticholinesterase agents	0.007	0.992	0.000
T42.1 Iminostilbenes	0.008	0.992	0.000
T49.9 Topical agent, unspecified	0.007	0.992	0.000
T49.8 Other topical agents	0.007	0.992	0.000
T49.7 Dental drugs, topically applied	0.007	0.992	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.007	0.992	0.000
T49.5 Ophthalmological drugs and preparations	0.007	0.992	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.007	0.992	0.000
T49.3 Emollients, demulcents and protectants	0.007	0.992	0.000
T49.2 Local astringents and local detergents	0.007	0.992	0.000
T49.1 Antipruritics	0.007	0.992	0.000
C77 Secondary and unspecified malignant neoplasm of lymph nodes	0.008	0.992	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.007	0.993	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.007	0.993	0.000
T36.9 Systemic antibiotic, unspecified	0.007	0.993	0.000
T36.8 Other systemic antibiotics	0.007	0.993	0.000
T36.7 Antifungal antibiotics, systemically used	0.007	0.993	0.000
T36.6 Rifamycins	0.007	0.993	0.000
T36.5 Aminoglycosides	0.007	0.993	0.000
T36.4 Tetracyclines	0.007	0.993	0.000
T36.2 Chloramphenicol group	0.007	0.993	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.007	0.993	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.007	0.993	0.000
T42.3 Barbiturates	0.007	0.993	0.000
C77.4 Inguinal and lower limb lymph nodes	0.007	0.993	0.000
H31 Other disorders of choroid	0.000	0.993	0.007
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.007	0.993	0.000
C77.1 Intrathoracic lymph nodes	0.007	0.993	0.000
C82.9 Follicular non-Hodgkin's lymphoma, unspecified	0.007	0.993	0.000
H20.9 Iridocyclitis, unspecified	0.000	0.993	0.007
T50.1 Loop [high-ceiling] diuretics	0.006	0.993	0.000
H20.1 Chronic iridocyclitis	0.000	0.993	0.007
T50.8 Diagnostic agents	0.006	0.993	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.006	0.993	0.000
T42.2 Succinimides and oxazolidinediones	0.006	0.993	0.000
T50.4 Drugs affecting uric acid metabolism	0.006	0.993	0.000
H20 Iridocyclitis	0.000	0.993	0.007
M54.22 Cervicalgia (Cervical region)	0.000	0.994	0.006
T43.3 Phenothiazine antipsychotics and neuroleptics	0.006	0.994	0.000
C77.8 Lymph nodes of multiple regions	0.006	0.994	0.000
T50.7 Analeptics and opioid receptor antagonists	0.006	0.994	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.006	0.994	0.000
T50.5 Appetite depressants	0.006	0.994	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.006	0.994	0.000
T50.0 Mineralocorticoids and their antagonists	0.006	0.994	0.000
M22.2 Patellofemoral disorders	0.006	0.994	0.000
Z99.3 Dependence on wheelchair	0.006	0.994	0.000
C77.2 Intra-abdominal lymph nodes	0.006	0.994	0.000
H31.8 Other specified disorders of choroid	0.000	0.994	0.006
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.006	0.994	0.000
C79.1 Secondary malignant neoplasm of bladder and other and unspecified urinary organs	0.006	0.994	0.000
T40.6 Other and unspecified narcotics	0.006	0.994	0.000
C79 Secondary malignant neoplasm of other sites	0.006	0.994	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.006	0.994	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.006	0.994	0.000
T40.8 Lysergide [LSD]	0.006	0.994	0.000
T40.7 Cannabis (derivatives)	0.006	0.994	0.000
T40.3 Methadone	0.006	0.994	0.000
T40.1 Heroin	0.006	0.994	0.000
T40.0 Opium	0.006	0.994	0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.006	0.994	0.000
H32 Chorioretinal disorders in diseases classified elsewhere	0.000	0.994	0.006
M13.00 Polyarthritis, unspecified (Multiple sites)	0.000	0.994	0.006
H30 Chorioretinal inflammation	0.000	0.994	0.006
T46.4 Angiotensin-converting-enzyme inhibitors	0.005	0.994	0.000
T40.4 Other synthetic narcotics	0.006	0.994	0.000
C91.1 Chronic lymphocytic leukaemia	0.000	0.994	0.006
H17.9 Corneal scar and opacity, unspecified	0.000	0.994	0.006
H17 Corneal scars and opacities	0.000	0.994	0.006
C77.0 Lymph nodes of head, face and neck	0.005	0.995	0.000
T40.5 Cocaine	0.005	0.995	0.000
T36.0 Penicillins	0.005	0.995	0.000
Z99 Dependence on enabling machines and devices, not elsewhere classified	0.005	0.995	0.000
H15-H22 Disorders of sclera, cornea, iris and ciliary body	0.000	0.995	0.005
I77.1 Stricture of artery	0.000	0.995	0.005
H31.1 Choroidal degeneration	0.000	0.995	0.005
H31.9 Disorder of choroid, unspecified	0.000	0.995	0.005
H31.4 Choroidal detachment	0.000	0.995	0.005
H31.2 Hereditary choroidal dystrophy	0.000	0.995	0.005
C79.0 Secondary malignant neoplasm of kidney and renal pelvis	0.005	0.995	0.000
H31.0 Chorioretinal scars	0.000	0.995	0.005
Z99.1 Dependence on respirator	0.005	0.995	0.000
C77.5 Intrapelvic lymph nodes	0.005	0.995	0.000
Z99.2 Dependence on renal dialysis	0.005	0.995	0.000
X62.9 Unspecified place	0.005	0.995	0.000
B97.8 Other viral agents as the cause of diseases classified to other chapters	0.005	0.995	0.000
H17.8 Other corneal scars and opacities	0.000	0.995	0.005
N85.2 Hypertrophy of uterus	0.005	0.995	0.000
H34 Retinal vascular occlusions	0.000	0.995	0.005
H20.8 Other iridocyclitis	0.000	0.995	0.005
C76-C80 Malignant neoplasms of ill-defined, secondary and unspecified sites	0.005	0.995	0.000
H20.2 Lens-induced iridocyclitis	0.000	0.995	0.005
C82 Follicular [nodular] non-Hodgkin's lymphoma	0.005	0.995	0.000
T39.1 4-Aminophenol derivatives	0.005	0.995	0.000
H18 Other disorders of cornea	0.000	0.995	0.005
C79.2 Secondary malignant neoplasm of skin	0.005	0.995	0.000
H31.3 Choroidal haemorrhage and rupture	0.000	0.995	0.005
N85 Other noninflammatory disorders of uterus, except cervix	0.005	0.995	0.000
H18.4 Corneal degeneration	0.000	0.995	0.005
M22 Disorders of patella	0.005	0.995	0.000
C82.2 Large cell, follicular	0.004	0.995	0.000
H18.8 Other specified disorders of cornea	0.000	0.995	0.005
H32.8 Other chorioretinal disorders in diseases classified elsewhere	0.000	0.996	0.004
H32.0 Chorioretinal inflammation in infectious and parasitic diseases classified elsewhere	0.000	0.996	0.004
H22 Disorders of iris and ciliary body in diseases classified elsewhere	0.000	0.996	0.004
H30.8 Other chorioretinal inflammations	0.000	0.996	0.004
H30.2 Posterior cyclitis	0.000	0.996	0.004
H30.1 Disseminated chorioretinal inflammation	0.000	0.996	0.004
H30.0 Focal chorioretinal inflammation	0.000	0.996	0.004
T40.2 Other opioids	0.004	0.996	0.000
C82.3 Follicular lymphoma grade IIIa	0.004	0.996	0.000
H20.0 Acute and subacute iridocyclitis	0.000	0.996	0.004
V18.2 Unspecified pedal cyclist injured in nontraffic accident	0.000	0.996	0.004
H15 Disorders of sclera	0.000	0.996	0.004
H30.9 Chorioretinal inflammation, unspecified	0.000	0.996	0.004
H17.1 Other central corneal opacity	0.000	0.996	0.004
H17.0 Adherent leukoma	0.000	0.996	0.004
M54.94 Dorsalgia, unspecified (Thoracic region)	0.000	0.996	0.004
Z99.9 Dependence on unspecified enabling machine and device	0.004	0.996	0.000
H36 Retinal disorders in diseases classified elsewhere	0.000	0.996	0.004
C82.1 Mixed small cleaved and large cell, follicular	0.004	0.996	0.000
C79.4 Secondary malignant neoplasm of other and unspecified parts of nervous system	0.004	0.996	0.000
C82.4 Follicular lymphoma grade IIIb	0.004	0.996	0.000
H18.9 Disorder of cornea, unspecified	0.000	0.996	0.004
H34.2 Other retinal artery occlusions	0.000	0.996	0.004
N85.5 Inversion of uterus	0.004	0.996	0.000
M22.3 Other derangements of patella	0.004	0.996	0.000
Z99.4 Dependence on artificial heart	0.004	0.996	0.000
Z99.0 Dependence on aspirator	0.004	0.996	0.000
H18.2 Other corneal oedema	0.000	0.996	0.004
H34.1 Central retinal artery occlusion	0.000	0.996	0.004
M22.4 Chondromalacia patellae	0.004	0.996	0.000
M54.2 Cervicalgia	0.000	0.996	0.004
N85.7 Haematometra	0.004	0.996	0.000
T93.8 Sequelae of other specified injuries of lower limb	0.000	0.996	0.004
M22.8 Other disorders of patella	0.004	0.996	0.000
C76 Malignant neoplasm of other and ill-defined sites	0.004	0.996	0.000
H21 Other disorders of iris and ciliary body	0.000	0.996	0.004
Z99.8 Dependence on other enabling machines and devices	0.004	0.996	0.000
H22.1 Iridocyclitis in other diseases classified elsewhere	0.000	0.996	0.004
V18.0 Driver injured in nontraffic accident	0.000	0.996	0.004
H34.0 Transient retinal artery occlusion	0.000	0.996	0.004
C79.9 Secondary malignant neoplasm, unspecified site	0.004	0.996	0.000
C82.6 Cutaneous follicle centre lymphoma	0.004	0.996	0.000
C82.5 Diffuse follicle centre lymphoma	0.004	0.996	0.000
C79.6 Secondary malignant neoplasm of ovary	0.004	0.996	0.000
M54.29 Cervicalgia-Site unspe	0.000	0.996	0.004
T42.4 Benzodiazepines	0.004	0.996	0.000
Z36.8 Other antenatal screening	0.000	0.996	0.004
C91.0 Acute lymphoblastic leukaemia	0.000	0.996	0.004
H18.7 Other corneal deformities	0.000	0.996	0.004
H18.3 Changes in corneal membranes	0.000	0.996	0.004
H18.0 Corneal pigmentations and deposits	0.000	0.996	0.004
S22.00 Fracture of thoracic vertebra (closed)	0.000	0.996	0.004
M22.0 Recurrent dislocation of patella	0.004	0.996	0.000
H19 Disorders of sclera and cornea in diseases classified elsewhere	0.000	0.996	0.004
N85.3 Subinvolution of uterus	0.004	0.996	0.000
I77 Other disorders of arteries and arterioles	0.000	0.996	0.004
C80 Malignant neoplasm without specification of site	0.004	0.996	0.000
X62 Intentional self-poisoning by and exposure to narcotics and psychodysleptics [hallucinogens], not elsewhere classified	0.004	0.996	0.000
H34.9 Retinal vascular occlusion, unspecified	0.000	0.996	0.003
I77.6 Arteritis, unspecified	0.000	0.996	0.004
R90.8 Other abnormal findings on diagnostic imaging of central nervous system	0.004	0.996	0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.004	0.996	0.000
M22.1 Recurrent subluxation of patella	0.003	0.996	0.000
H15.0 Scleritis	0.000	0.996	0.003
H15.1 Episcleritis	0.000	0.996	0.003
H33.4 Traction detachment of retina	0.000	0.996	0.004
H21.2 Degeneration of iris and ciliary body	0.000	0.996	0.003
I77.8 Other specified disorders of arteries and arterioles	0.000	0.996	0.003
C82.0 Small cleaved cell, follicular	0.003	0.997	0.000
H15.8 Other disorders of sclera	0.000	0.997	0.003
H22.8 Other disorders of iris and ciliary body in diseases classified elsewhere	0.000	0.997	0.003
H22.0 Iridocyclitis in infectious and parasitic diseases classified elsewhere	0.000	0.997	0.003
C91 Lymphoid leukaemia	0.000	0.997	0.003
C76.3 Pelvis	0.003	0.997	0.000
C82.7 Other types of follicular non-Hodgkin's lymphoma	0.003	0.997	0.000
H15.9 Disorder of sclera, unspecified	0.000	0.997	0.003
H21.0 Hyphaema	0.000	0.997	0.003
B97 Viral agents as the cause of diseases classified to other chapters	0.003	0.997	0.000
V18 Pedal cyclist injured in noncollision transport accident	0.000	0.997	0.003
N85.6 Intra-uterine synechiae	0.003	0.997	0.000
B96.5 Pseudomonas (aeruginosa)(mallei)(pseudomallei) as the cause of diseases classified to other chapters	0.000	0.997	0.003
H36.8 Other retinal disorders in diseases classified elsewhere	0.000	0.997	0.003
K62.4 Stenosis of anus and rectum	0.003	0.997	0.000
N85.1 Endometrial adenomatous hyperplasia	0.003	0.997	0.000
H21.1 Other vascular disorders of iris and ciliary body	0.000	0.997	0.003
M54.27 Cervicalgia-Lumbosacral	0.000	0.997	0.003
M54.26 Cervicalgia-Lumbar	0.000	0.997	0.003
M54.25 Cervicalgia-Thoracolumbar	0.000	0.997	0.003
M54.24 Cervicalgia-Thoracic	0.000	0.997	0.003
M54.21 Cervicalgia (Occipito-atlanto-axial region)	0.000	0.997	0.003
M54.20 Cervicalgia-Mult site	0.000	0.997	0.003
B97.7 Papillomavirus as the cause of diseases classified to other chapters	0.003	0.997	0.000
B97.4 Respiratory synctial virus as the cause of diseases classified to other chapters	0.003	0.997	0.000
C76.8 Overlapping lesion of other and ill-defined sites	0.003	0.997	0.000
C76.7 Other ill-defined sites	0.003	0.997	0.000
C76.5 Lower limb	0.003	0.997	0.000
C76.4 Upper limb	0.003	0.997	0.000
C76.2 Abdomen	0.003	0.997	0.000
C76.1 Thorax	0.003	0.997	0.000
F81.9 Developmental disorder of scholastic skills, unspecified	0.000	0.997	0.003
H18.1 Bullous keratopathy	0.000	0.997	0.003
M54.28 Cervicalgia-Sacral/sacrococ	0.000	0.997	0.003
H21.4 Pupillary membranes	0.000	0.997	0.003
H21.3 Cyst of iris, ciliary body and anterior chamber	0.000	0.997	0.003
M22.9 Disorder of patella, unspecified	0.003	0.997	0.000
H18.6 Keratoconus	0.000	0.997	0.003
I77.9 Disorder of arteries and arterioles, unspecified	0.000	0.997	0.003
M54.23 Cervicalgia (Cervicothoracic region)	0.000	0.997	0.003
C80.0 Malignant neoplasm, primary site unknown, so stated	0.003	0.997	0.000
H19.8 Other disorders of sclera and cornea in diseases classified elsewhere	0.000	0.997	0.003
H19.2 Keratitis and keratoconjunctivitis in other infectious and parasitic diseases classified elsewhere	0.000	0.997	0.003
H19.0 Scleritis and episcleritis in diseases classified elsewhere	0.000	0.997	0.003
I77.5 Necrosis of artery	0.000	0.997	0.003
I77.4 Coeliac artery compression syndrome	0.000	0.997	0.003
I77.3 Arterial fibromuscular dysplasia	0.000	0.997	0.003
T93 Sequelae of injuries of lower limb	0.000	0.997	0.003
C91.4 Hairy-cell leukaemia	0.000	0.997	0.003
K29.4 Chronic atrophic gastritis	0.000	0.997	0.003
T93.0 Sequelae of open wound of lower limb	0.000	0.997	0.003
X62.0 Home	0.003	0.997	0.000
X62.8 Other specified place	0.003	0.997	0.000
X62.7 Farm	0.003	0.997	0.000
X62.6 Industrial and construction area	0.003	0.997	0.000
X62.5 Trade and service area	0.003	0.997	0.000
X62.4 Street and highway	0.003	0.997	0.000
X62.3 Sports and athletics area	0.003	0.997	0.000
X62.2 School, other institution and public administrative area	0.003	0.997	0.000
X62.1 Residential institution	0.003	0.997	0.000
M22.10 Recurrent subluxation of patella, unspecified knee	0.003	0.997	0.000
O36.6 Maternal care for excessive foetal growth	0.000	0.997	0.003
H19.3 Keratitis and keratoconjunctivitis in other diseases classified elsewhere	0.000	0.997	0.003
H19.1 Herpesviral keratitis and keratoconjunctivitis	0.000	0.997	0.003
C91.8 Mature B-cell leukaemia Burkitt-type	0.000	0.997	0.003
C91.7 Other lymphoid leukaemia	0.000	0.997	0.003
C91.6 Prolymphocytic leukaemia of T-cell type	0.000	0.997	0.003
C91.3 Prolymphocytic leukaemia	0.000	0.997	0.003
C91.2 Subacute lymphocytic leukaemia	0.000	0.997	0.003
H21.5 Other adhesions and disruptions of iris and ciliary body	0.000	0.997	0.003
C73 Malignant neoplasm of thyroid gland	0.000	0.997	0.003
C76.0 Head, face and neck	0.003	0.997	0.000
M25.75 Osteophyte (Pelvic region and thigh)	0.003	0.997	0.000
H21.9 Disorder of iris and ciliary body, unspecified	0.000	0.997	0.003
T93.5 Sequelae of injury of muscle and tendon of lower limb	0.000	0.997	0.003
B97.6 Parvovirus as the cause of diseases classified to other chapters	0.003	0.997	0.000
B97.5 Reovirus as the cause of diseases classified to other chapters	0.003	0.997	0.000
B97.3 Retrovirus as the cause of diseases classified to other chapters	0.003	0.997	0.000
B97.2 Coronavirus as the cause of diseases classified to other chapters	0.003	0.997	0.000
B97.1 Enterovirus as the cause of diseases classified to other chapters	0.003	0.997	0.000
B97.0 Adenovirus as the cause of diseases classified to other chapters	0.003	0.997	0.000
V18.9 Unspecified pedal cyclist injured in traffic accident	0.000	0.997	0.003
V18.4 Driver injured in traffic accident	0.000	0.997	0.003
V18.5 Passenger injured in traffic accident	0.000	0.997	0.003
X68.9 Unspecified place	0.003	0.997	0.000
V18.3 Person injured while boarding or alighting	0.000	0.997	0.003
Y65.8 Other specified misadventures during surgical and medical care	0.003	0.997	0.000
S32.40 Fracture of acetabulum (closed)	0.000	0.997	0.003
X68 Intentional self-poisoning by and exposure to pesticides	0.003	0.997	0.000
H80.9 Otosclerosis, unspecified	0.003	0.997	0.000
T93.3 Sequelae of dislocation, sprain and strain of lower limb	0.000	0.997	0.003
C80.9 Malignant neoplasm, unspecified	0.003	0.997	0.000
X60-X84 Intentional self-harm	0.003	0.997	0.000
K83.0 Cholangitis	0.003	0.997	0.000
H18.5 Hereditary corneal dystrophies	0.000	0.997	0.002
C77.3 Axillary and upper limb lymph nodes	0.003	0.997	0.000
I77.2 Rupture of artery	0.000	0.997	0.002
T50.9 Other and unspecified drugs, medicaments and biological substances	0.002	0.997	0.000
X67 Intentional self-poisoning by and exposure to other gases and vapours	0.002	0.997	0.000
X67.9 Unspecified place	0.002	0.997	0.000
I77.0 Arteriovenous fistula, acquired	0.000	0.998	0.002
C91.5 Adult T-cell leukaemia	0.000	0.998	0.002
T93.9 Sequelae of unspecified injury of lower limb	0.000	0.998	0.002
H33 Retinal detachments and breaks	0.000	0.998	0.002
Q82.8 Other specified congenital malformations of skin	0.002	0.998	0.000
E89.2 Postprocedural hypoparathyroidism	0.002	0.998	0.000
H21.8 Other specified disorders of iris and ciliary body	0.000	0.998	0.002
T93.6 Sequelae of crushing injury and traumatic amputation of lower limb	0.000	0.998	0.002
T93.4 Sequelae of injury of nerve of lower limb	0.000	0.998	0.002
X62.09 Intentional self-poisoning by and exposure to narcotics and psychodysleptics [hallucinogens], not elsewhere classified: Home: During unspecified activity	0.002	0.998	0.000
G71.1 Myotonic disorders	0.002	0.998	0.000
N85.9 Noninflammatory disorder of uterus, unspecified	0.002	0.998	0.000
C91.9 Lymphoid leukaemia, unspecified	0.000	0.998	0.002
H34.8 Other retinal vascular occlusions	0.000	0.998	0.002
X63 Intentional self-poisoning by and exposure to other drugs acting on the autonomic nervous system	0.002	0.998	0.000
V18.1 Passenger injured in nontraffic accident	0.000	0.998	0.002
X61 Intentional self-poisoning by and exposure to antiepileptic, sedative-hypnotic, anti-Parkinsonism and psychotropic drugs, not elsewhere classified	0.002	0.998	0.000
V18.49 Pedal cyclist injured in noncollision transport accident; driver injured in traffic accident ; during unspecified activity	0.000	0.998	0.002
V18.99 Pedal cyclist injured in noncollision transport accident; unspecified pedal cyclist injured in traffic accident; during unspecified activity	0.000	0.998	0.002
X60 Intentional self-poisoning by and exposure to nonopioid analgesics, antipyretics and antirheumatics	0.002	0.998	0.000
C48.0 Retroperitoneum	0.000	0.998	0.002
X68.8 Other specified place	0.002	0.998	0.000
X68.7 Farm	0.002	0.998	0.000
X68.6 Industrial and construction area	0.002	0.998	0.000
X68.5 Trade and service area	0.002	0.998	0.000
X68.4 Street and highway	0.002	0.998	0.000
X68.3 Sports and athletics area	0.002	0.998	0.000
X68.2 School, other institution and public administrative area	0.002	0.998	0.000
X68.1 Residential institution	0.002	0.998	0.000
X68.0 Home	0.002	0.998	0.000
X84 Intentional self-harm by unspecified means	0.002	0.998	0.000
X83 Intentional self-harm by other specified means	0.002	0.998	0.000
X82 Intentional self-harm by crashing of motor vehicle	0.002	0.998	0.000
X81 Intentional self-harm by jumping or lying before moving object	0.002	0.998	0.000
X80 Intentional self-harm by jumping from a high place	0.002	0.998	0.000
X79 Intentional self-harm by blunt object	0.002	0.998	0.000
X77 Intentional self-harm by steam, hot vapours and hot objects	0.002	0.998	0.000
X76 Intentional self-harm by smoke, fire and flames	0.002	0.998	0.000
X75 Intentional self-harm by explosive material	0.002	0.998	0.000
X74 Intentional self-harm by other and unspecified firearm discharge	0.002	0.998	0.000
X73 Intentional self-harm by rifle, shotgun and larger firearm discharge	0.002	0.998	0.000
X72 Intentional self-harm by handgun discharge	0.002	0.998	0.000
X71 Intentional self-harm by drowning and submersion	0.002	0.998	0.000
X70 Intentional self-harm by hanging, strangulation and suffocation	0.002	0.998	0.000
X66 Intentional self-poisoning by and exposure to organic solvents and halogenated hydrocarbons and their vapours	0.002	0.998	0.000
X64 Intentional self-poisoning by and exposure to other and unspecified drugs, medicaments and biological substances	0.002	0.998	0.000
Y83.5 Amputation of limb(s)	0.000	0.998	0.002
Z90.0 Acquired absence of part of head and neck	0.002	0.998	0.000
R03 Abnormal blood-pressure reading, without diagnosis	0.000	0.998	0.002
X67.8 Other specified place	0.002	0.998	0.000
X67.7 Farm	0.002	0.998	0.000
X67.6 Industrial and construction area	0.002	0.998	0.000
X67.5 Trade and service area	0.002	0.998	0.000
X67.4 Street and highway	0.002	0.998	0.000
X67.3 Sports and athletics area	0.002	0.998	0.000
X67.2 School, other institution and public administrative area	0.002	0.998	0.000
X67.1 Residential institution	0.002	0.998	0.000
X67.0 Home	0.002	0.998	0.000
D22.4 Melanocytic naevi of scalp and neck	0.002	0.998	0.000
F00.9 Dementia in Alzheimer's disease, unspecified	0.002	0.998	0.000
N42.8 Other specified disorders of prostate	0.002	0.998	0.000
N85.4 Malposition of uterus	0.002	0.998	0.000
X69 Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances	0.002	0.998	0.000
S22.0 Fracture of thoracic vertebra	0.000	0.998	0.002
X65 Intentional self-poisoning by and exposure to alcohol	0.002	0.998	0.000
C79.5 Secondary malignant neoplasm of bone and bone marrow	0.002	0.998	0.000
X63.0 Home	0.002	0.998	0.000
K06.8 Other specified disorders of gingiva and edentulous alveolar ridge	0.002	0.998	0.000
T93.1 Sequelae of fracture of femur	0.000	0.998	0.002
X61.4 Street and highway	0.002	0.998	0.000
E89.6 Postprocedural adrenocortical(-medullary) hypofunction	0.002	0.998	0.000
X60.8 Other specified place	0.002	0.998	0.000
F81 Specific developmental disorders of scholastic skills	0.000	0.998	0.002
M62.86 Other specified disorders of muscle (Lower leg)	0.002	0.998	0.000
M13.0 Polyarthritis, unspecified	0.000	0.998	0.002
H16 Keratitis	0.000	0.998	0.002
S20.8 Superficial injuries of other and unspecified parts of thorax	0.000	0.998	0.002
X63.9 Unspecified place	0.002	0.998	0.000
X63.8 Other specified place	0.002	0.998	0.000
X63.7 Farm	0.002	0.998	0.000
X63.6 Industrial and construction area	0.002	0.998	0.000
X63.5 Trade and service area	0.002	0.998	0.000
X63.4 Street and highway	0.002	0.998	0.000
X63.3 Sports and athletics area	0.002	0.998	0.000
X63.2 School, other institution and public administrative area	0.002	0.998	0.000
X63.1 Residential institution	0.002	0.998	0.000
M54.36 Sciatica (Lumbar region)	0.000	0.998	0.002
X60.9 Unspecified place	0.002	0.998	0.000
X60.0 Home	0.002	0.998	0.000
X60.7 Farm	0.002	0.998	0.000
X60.6 Industrial and construction area	0.002	0.998	0.000
X60.5 Trade and service area	0.002	0.998	0.000
X60.4 Street and highway	0.002	0.998	0.000
X60.3 Sports and athletics area	0.002	0.998	0.000
X60.1 Residential institution	0.002	0.998	0.000
X61.9 Unspecified place	0.002	0.998	0.000
X61.8 Other specified place	0.002	0.998	0.000
X61.0 Home	0.002	0.998	0.000
X61.7 Farm	0.002	0.998	0.000
X61.6 Industrial and construction area	0.002	0.998	0.000
X61.5 Trade and service area	0.002	0.998	0.000
X61.3 Sports and athletics area	0.002	0.998	0.000
X61.2 School, other institution and public administrative area	0.002	0.998	0.000
X61.1 Residential institution	0.002	0.998	0.000
X60.2 School, other institution and public administrative area	0.002	0.998	0.000
N13.1 Hydronephrosis with ureteral stricture, not elsewhere classified	0.002	0.998	0.000
X64.9 Unspecified place	0.002	0.998	0.000
X64.0 Home	0.002	0.998	0.000
X64.8 Other specified place	0.002	0.998	0.000
X64.7 Farm	0.002	0.998	0.000
X64.6 Industrial and construction area	0.002	0.998	0.000
X64.5 Trade and service area	0.002	0.998	0.000
X64.4 Street and highway	0.002	0.998	0.000
X64.3 Sports and athletics area	0.002	0.998	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations